Skip to main content
US EQUITIES OPEN CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
LN

LNTHStockLantheus Holdings Inc

Nasdaq Global Market · Healthcare · US

$101.80 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment LNTH's does — no target price to set, unlike a price alert.

Stable Ratio screen, 6 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-12
6 of 7 pass our own screen — the standards disagree
HTR non-permissible income 1.52%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
Scores: 1 bullish / 1 bearish
44
of 100
Setup confidence — system conviction, not win probabilityD

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure4 of 5 timeframes bullish · 82.6% aligned
VWAPPrice holding above VWAP ($101.61)
VolumeRelative volume 3.1× the 20-day average
Momentum10-day rate of change +0.7%
Overall readNEUTRAL — No Edge

Lantheus Holdings Inc (LNTH) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Price target
$105.99
+4.1% · 7 analysts
Institutional own.
100.2% *
of shares
Momentum (10d)
+0.7%
rate of change
SMC grade
D · 44
82.6% aligned
1.52%
Non-permissible income — HTR, from filings (2025-12-31)
D · 44
SMC grade — 82.6% timeframe alignment
+0.7%
Rate of change (10d)
$105.99
Price target (+4.1%) · 7 analysts
100.2%
Institutional ownership *

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to LNTH’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $6.7B as of 2026-11-18.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 9.38% 30.00% Pass(20.6pp buffer)
Interest-bearing investments 10.29% 30.00% Pass(19.7pp buffer)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
Usmani Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 25.42% 33.00% Pass(7.6pp buffer)
Interest-bearing investments 27.90% 33.00% Pass(5.1pp buffer)
Non-liquid assets 58.02% at least 20.00% Pass(38.0pp above the floor)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
MSCI Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 25.42% 33.33% Pass(7.9pp buffer)
Cash + interest-bearing securities 27.90% 33.33% Pass(5.4pp buffer)
Accounts receivable 41.98% 33.33% Fail(8.6pp over)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 23.28% 33.33% Pass(10.1pp buffer)
Cash + interest-bearing securities 27.90% 33.33% Pass(5.4pp buffer)
Accounts receivable 41.98% 50.00% Pass(8.0pp buffer)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.59% 33.00% Pass(21.4pp buffer)
Cash + interest-bearing securities 12.72% 33.00% Pass(20.3pp buffer)
Accounts receivable 6.42% 33.00% Pass(26.6pp buffer)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.76% 33.00% Pass(21.2pp buffer)
Cash + interest-bearing securities 12.91% 49.00% Pass(36.1pp buffer)
Accounts receivable 6.51% 49.00% Pass(42.5pp buffer)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 11.76% 33.33% Pass(21.6pp buffer)
Cash + interest-bearing securities 12.91% 33.33% Pass(20.4pp buffer)
Accounts receivable 19.43% 49.00% Pass(29.6pp buffer)
Non-permissible income 1.52% 5.00% Pass(3.5pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 3.5pts
Usmani (% of total assets)non permissible income ratio 3.5pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 3.5pts
MSCI Islamic Index (% of total assets)receivables ratio 8.6pts

The numbers the ratios are built from

Read from LNTH's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $1.5B 2025-12-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $571.7M 2026-09-30 LongTermDebtAndCapitalLeaseObligations, LongTermDebtCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $685.3M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $2.5B 2026-09-30 Assets
Market capDenominator for AAOIFI $6.7B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $5.6B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $5.6B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $23.4M 2025-12-31 InterestIncomeOther

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-05, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-26, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$2.5B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Interest-bearing debt$571.7M
    LongTermDebtAndCapitalLeaseObligations $571.1M · period ended 2026-09-30 · 10-Q filed 2026-11-05
    LongTermDebtCurrent $605.0K · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Cash and interest-bearing securities$685.3M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Receivables$345.7M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Revenue$1.5B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Interest income (non-permissible)$23.4M
    InterestIncomeOther · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Market cap$6.7B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for LNTH. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Unverified → Pass filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 6 pass and 1 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (9.4% against a 30% line) would only fail if the market cap fell by 69%, to $2.1B.

AAOIFI's investments ratio (10.3% against a 30% line) would only fail if the market cap fell by 66%, to $2.3B.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Drug Manufacturers - Specialty & Generic listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
GALDYGalderma Group AG - ADR $47.7B —
HLNHaleon plc - ADR $44.4B —
NBIXNeurocrine Biosciences, Inc. $15.9B —
RDYDr. Reddy`s Laboratories Ltd. - ADR $10.1B —
ALKSAlkermes plc $7.9B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold LNTH

10 of the 239 funds whose filed holdings we currently hold own LNTH shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns LNTH.

You may already own it

Widely held U.S. index funds. If you own one, you own LNTH through it. None of them is a Shariah fund; the last column is our look-through of each.

FundLNTH in fundFund compliant by weight
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.01% 54%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.01% 54%
SCHB Schwab U.S. Broad Market ETF 0.01% 53%
Other funds
FundLNTH in fundFund compliant by weight
JHSC John Hancock Multifactor Small Cap ETF 0.37% 36%
TMSL T. Rowe Price Small-Mid Cap ETF 0.23% 43%
PLARX SmallCap Value Fund II 0.17% 26%
IJJ iShares S&P Mid-Cap 400 Value ETF 0.13% 30%
AVLV Avantis U.S. Large Cap Value ETF 0.06% 38%
AVUS Avantis U.S. Equity ETF 0.04% 49%
TEIHX Nuveen Equity Index Fund 0.01% 51%

Sorted by LNTH’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names LNTH once, so a bond is not counted as the shares; 3 more funds name LNTH in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding LNTH
InvestorFirmPositionWeightAs of
Israel Englander Millennium Management $198M 0.1% 2026-09-30
Ken Griffin Citadel Advisors $72M 0.0% 2026-09-30
George Soros Soros Fund Management $36M 0.4% 2026-09-30
Hotchkis & Wiley Hotchkis & Wiley Capital Management $15M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $13M 0.0% 2026-09-30
David Shaw D. E. Shaw & Co. $1M 0.0% 2026-09-30
First Eagle First Eagle Investment Management $1M 0.0% 2026-09-30
Mario Gabelli GAMCO Investors $1M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $1M 0.0% 2026-09-30
Ray Dalio Bridgewater Associates $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

110.9496.4081.8767.3352.792025-11-182026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
101.50
S2
101.58
S1
101.69
PIVOT
101.77
R1
101.88
R2
101.96
R3
102.07

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
98.50 – 100.94
±1.22% from 99.72, made 2026-09-26 · resolves 2026-10-03
STRONG SELL
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)65.80NEUTRAL
Stochastic %K (14)95.71SELL
CCI (20)111.44SELL
Williams %R (14)-4.29SELL
MACD (12,26,9)0.11BUY
ROC (10)0.65BUY
Momentum (10)0.66BUY
EMA (10)101.41BUY
SMA (10)101.37BUY
EMA (20)101.04BUY
SMA (20)100.84BUY
EMA (30)100.85BUY
SMA (30)100.58BUY
EMA (50)100.70BUY
SMA (50)100.39BUY
EMA (100)99.16BUY
SMA (100)101.57BUY
EMA (200)90.80BUY
SMA (200)93.64BUY

About Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

lantheus.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

⚪ NEUTRAL — No Edge

Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.

Scores: 1 bullish / 1 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 64
⏰ 4H BULLISH 37
🕐 1H RANGING 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+0.7%
Rate of change (10d)
3.1×
Volume vs its 20-day average
0.42
MACD (no fresh cross)
$101.79
Volume POC (today)
$101.77 – $101.82
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.